27.07.2013 Views

hexachlorobutadiene - Davidborowski.com

hexachlorobutadiene - Davidborowski.com

hexachlorobutadiene - Davidborowski.com

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

HEXACHLOROBUTADIENE 31<br />

2. HEALTH EFFECTS<br />

from dams exposed to <strong>hexachlorobutadiene</strong> at dose levels of 20 mg/kg/day throughout gestation and<br />

lactation; body weights were not reduced in pups from dams exposed to 2 mg/kg/day. No other signs<br />

of fetotoxicity were evident at doses up to 20 mg/kg/day. Teratogenic effects were not observed nor<br />

was <strong>hexachlorobutadiene</strong> embryotoxic at the doses tested (Schwetz et al. 1977).<br />

The highest NOAEL values and all LOAEL values from each reliable study for developmental effects<br />

in each species and duration category are recorded in Table 2-2 and plotted in Figure 2-2.<br />

2.2.2.7 Genotoxic Effects<br />

No studies were located regarding genotoxic effects in humans after oral exposure to<br />

<strong>hexachlorobutadiene</strong>.<br />

In animals, there is some evidence that <strong>hexachlorobutadiene</strong> interacts with genetic material. Male rats<br />

administered a single gavage dose of <strong>hexachlorobutadiene</strong> (20 mg/kg/day) showed a 40% increase in<br />

renal deoxyribonucleic acid (DNA) repair and 0.78 alkylations per million nucleotides (Stott et al.<br />

1981). On the other hand, when <strong>hexachlorobutadiene</strong> was administered in the diet, it did not cause<br />

chromosomal aberrations in rat bone marrow cells (Schwetz et al. 1977).<br />

Other genotoxicity studies are discussed in Section 2.4.<br />

2.2.2.8 Cancer<br />

No studies were located regarding carcinogenic effects in humans after oral exposure to<br />

<strong>hexachlorobutadiene</strong>.<br />

Studies in rats reported renal tubular adenomas and adenocarcinomas in male and female animals at<br />

doses of 20 mg/kg/day (Kociba et al. 1977a). Metastasis to the lungs was observed. Combined<br />

incidences of renal tubular neoplasms in males (9/39, 23 %) and in females (6/40, 15 %) increased<br />

(p < 0.05) over controls (males-l/90, females-0/90, 0%). The tumor incidence was not increased in<br />

the 0.2 and 2 mg/kg/day dose groups but there were some indications of hyperplasia in animals<br />

exposed to 2 mg/kg/day. The EPA (1990f) evaluated these data and calculated a human potency<br />

factor of 7.8x10 -2 (mg/kg/day) -1 (q1*), representing a 95% upper confidence limit of extra lifetime

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!